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Abstract Six chimeras of the skeletal muscle (RyR1) and
cardiac muscle (RyR2) Ca2+ release channels (ryanodine
receptors) previously used to identify RyR1 dihydropyridine
receptor interactions [Nakai et al. (1998) J. Biol. Chem. 273,
13403] were expressed in HEK293 cells to assess their Ca2+
dependence in [3H]ryanodine binding and single channel mea-
surements. The results indicate that the C-terminal one-fourth
has a major role in Ca2+ activation and inactivation of RyR1.
Further, our results show that replacement of RyR1 regions with
corresponding RyR2 regions can result in loss and/or reduction of
[3H]ryanodine binding affinity while maintaining channel activ-
ity.
z 1999 Federation of European Biochemical Societies.
Key words: Ca2 release channel; Ryanodine receptor;
Skeletal muscle; Cardiac muscle; HEK293 cell
1. Introduction
Ryanodine receptors (RyRs) are Ca2 channels that control
the Ca2 levels of cells by releasing Ca2 from the sarco/en-
doplasmic reticulum (SR), an intracellular storage compart-
ment. Mammalian tissues express three RyR isoforms en-
coded by separate genes. RyR1 and RyR2 are primarily
expressed in skeletal and cardiac muscle, respectively, and in
brain and other tissues at lower levels [1^3]. RyR3 is present
in diaphragm and slow twitch skeletal muscles, and other
tissues at low levels. RyRs consist of four large subunits,
each with a molecular mass of V560 kDa, and four small
12 kDa FK506 binding proteins [1,3^5].
The two dominant mammalian RyR1 and RyR2 isoforms
are highly related proteins, however, there are some important
di¡erences in the way the two channels are regulated. One of
the major di¡erences relates to the mechanism of in vivo
activation. In cardiac muscle, surface membrane dihydropyr-
idine-sensitive (L-type) Ca2 channels (DHPRs) mediate the
in£ux of a small amount of Ca2 during an action potential
that opens the high-conductance SR RyR2s [6]. In contrast, in
mammalian skeletal muscle, voltage-sensing surface mem-
brane DHPRs open closely apposed SR RyR1s through direct
protein interactions [7]. A second major di¡erence between
RyR1 and RyR2 relates to their response to Ca2. Both iso-
forms show a characteristic biphasic Ca2 dependence of
channel opening, indicating high a⁄nity activation and low
a⁄nity inactivation sites [4,5]. The a⁄nity of the inactivation
site for Ca2 is about 10-fold lower for RyR2 than for RyR1.
A second di¡erence is that RyR2 is nearly fully activated by
Ca2, whereas RyR1 can be only partially activated by Ca2
in the absence of other channel e¡ectors.
In the present study, several RyR1/RyR2 chimeras previ-
ously used to identify RyR1-DHPR interactions [8] were ex-
pressed in human embryonic kidney (HEK293) cells. The
Ca2 dependence of expressed proteins was assessed in
[3H]ryanodine binding and single channel measurements.
Our results suggest that the C-terminus has a role in regula-
tion of RyR1 by Ca2.
2. Materials and methods
2.1. Materials
HEK293 cells were obtained from the Tissue Culture Facility of
Lineberger Cancer Center at the University of North Carolina,
[3H]ryanodine from Dupont NEN (Boston, MA), unlabeled ryano-
dine from Calbiochem (La Jolla, CA), and phospholipids from Avanti
Polar Lipids (Birmingham, AL). All other chemicals were of analyt-
ical grade.
2.2. Expression of RyRs
Construction of full-length RyR1 [9] and RyR2 [10] cDNAs and
RyR1/RyR2 chimeras [8] has been described. RyR cDNAs were
cloned into pCIneo (Promega, Madison, WI) and transiently ex-
pressed in HEK293 cells using the Lipofectamine Plus (Gibco BRL,
Grand Island, NY) method according to the manufacturer’s instruc-
tions. Cells were maintained in DMEM-H medium containing 10%
fetal bovine serum at 37‡C in 5% CO2 and plated the day before
transfection. For each 10 cm tissue culture dish, 6 Wg DNA and
30 Wl Lipofectamine were used. Cells were harvested 42^46 h after
transfection.
2.3. Membrane preparation
Cells were washed twice with 4 ml ice-cold PBS containing 1 mM
EDTA and protease inhibitors (0.2 mM Pefabloc, 100 nM aprotinin,
50 WM leupeptin, 1 WM pepstatin, and 1 mM benzamidine), and
harvested in the same solution by removal from the plates by scrap-
ing. Cells were collected by centrifugation, resuspended in the above
solution and homogenized with a Tekmar Tissumizer for 5 s at a
setting of 13 500 rpm. Cell homogenates were centrifuged for 1 h at
100 000Ug, resuspended in the above solution without EDTA, pel-
leted and ¢nally taken up in a bu¡er containing 10 mM imidazole, pH
7.0, 0.3 M sucrose, 20 WM leupeptin and 0.2 mM Pefabloc, and stored
at 380‡C. Rabbit skeletal and cardiac muscle SR membranes enriched
in Ca2 release activities were prepared as described [11].
2.4. Puri¢cation and reconstitution
Skeletal and cardiac muscle SR membranes (1 mg protein/ml) and
expressed RyRs from 2^4 culture dishes were solubilized for 10 min at
room temperature in 1.5 ml of a bu¡er containing 5 mg/ml phospha-
tidylcholine and 1.45% (3-[3-cholamido-propyl)dimethylammonio]-1-
propanesulfonate) (CHAPS), isolated by rate density centrifugation,
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and reconstituted into proteoliposomes by removal of CHAPS by
dialysis [12].
2.5. [3H]Ryanodine binding
Ryanodine is a plant alkaloid that binds with high a⁄nity and
speci¢city to RyRs. It is widely used as an indicator of channel ac-
tivity due to its preferential binding to open channels [4,5]. Unless
otherwise indicated, membranes of 1/12 culture dish were incubated
with 2 nM [3H]ryanodine at 24‡C in 100 Wl of 20 mM imidazole, pH
7.0, 0.25 M KCl, 0.15 M sucrose, 0.2 mM Pefabloc, 10 WM leupeptin,
and the indicated Ca2 concentrations. Non-speci¢c binding was de-
termined using a 1000-fold excess of unlabeled ryanodine. After 20 h,
aliquots of the samples were diluted with 20 volumes of ice-cold water
and placed on Whatman GF/B ¢lters preincubated with 2% polyethy-
leneimine in water. Filters were washed with 3U5 ml ice-cold 0.1 M
KCl, 1 mM KPIPES, pH 7.0. The radioactivity remaining with the
¢lters was determined by liquid scintillation counting to obtain bound
[3H]ryanodine.
2.6. Single channel recordings
Single channel measurements were performed by fusing proteolipo-
somes containing the puri¢ed RyRs with Mueller-Rudin-type bilayers
containing 5:3:2 phosphatidylethanolamine:phosphatidylserine:phos-
phatidylcholine (25 mg phospholipid per ml n-decane) [11]. The side
of the bilayer to which the proteoliposomes were fused was de¢ned as
the cis side. The trans side was de¢ned as ground. Puri¢ed channels
were recorded in symmetric 0.25 M KCl or asymmetric 0.4 M cis KCl/
0.02 M trans KCl media containing 20 mM KHEPES, pH 7.4. Addi-
tions were made to the cis bilayer chamber as indicated in the text
because the large cytosolic regulatory region of native channels faced
the cis (cytosolic) chamber in a majority (s 98%) of the recordings
[11]. Electrical signals were ¢ltered at 2 kHz, digitized at 10 kHz and
analyzed as described previously [11].
3. Results
RyR1 and RyR2 display several signi¢cant di¡erences re-
lating to their regulation by Ca2 (see Secton 1). We ration-
alized that six RyR1/RyR2 chimeras previously constructed to
identify skeletal muscle RyR-DHPR interactions [8] could be
used to identify regions that are important for the regulation
of RyRs by Ca2. In the six RyR1/RyR2 chimeras varying
regions of RyR1 are replaced with corresponding regions of
RyR2 (Fig. 1). Common to all six chimeras is a RyR2 3687^
4968 amino acid C-terminal region. This region is predicted to
encompass the transmembrane-spanning pore region as well
as part of the large N-terminal cytoplasmic foot region of
RyRs [4,5].
3.1. [3H]Ryanodine binding to RyR1/RyR2 chimeras
Response of RyR1/RyR2 chimeras to Ca2 was investi-
gated by determining the [3H]ryanodine binding properties
of cell membrane fractions and by carrying out single channel
measurements with puri¢ed receptor preparations. HEK293
cells transfected with the full-length RyR1 and RyR2 cDNAs
showed a biphasic Ca2 dependence of [3H]ryanodine binding
typical of native receptors (Fig. 2). [3H]Ryanodine binding to
both receptors was negligible at 0.1 WM free Ca2 and was
half-maximal at V5 WM free Ca2. Binding to RyR1 was
maximal at V20 WM free Ca2 and to RyR2 at V1 mM
Ca2. As observed for native receptors [13], an V10-fold
higher Ca2 concentration was required for inhibition of the
recombinant RyR2 than recombinant RyR1. Cells transfected
with the expression vector alone did not show speci¢c high-
a⁄nity [3H]ryanodine binding.
Membranes of cells transfected with R1, R2 and R9 chime-
ras showed a Ca2 activation/inactivation pro¢le similar to
Fig. 1. Schematic representation of RyR1/RyR2 chimeras. RyR1
amino acid sequences are represented by thick lines and those of
RyR2 by thin lines. Amino acid composition was as reported by
Nakai et al. [8].
Fig. 2. [3H]Ryanodine binding to recombinant full-length RyR1 and
RyR2 and chimeras. Ca2 dependence of speci¢c [3H]ryanodine
binding to RyR1 (a), RyR2 (P), R1 (b), R2 (S) and R9 (F) was
determined in 0.25 M KCl medium as described in Section 2. No
speci¢c [3H]ryanodine binding was detected for cells transfected
with the expression vector alone or R4, R6 or R10 cDNAs. Peak
[3H]ryanodine binding levels (100%) corresponded to 0.04 pmol/mg
protein for RyR1 and 0.2^0.4 pmol/mg protein for RyR2, R1, R2
and R9. Inset: Speci¢c [3H]ryanodine binding to RyR1, RyR2 and
R1 in 0.5 M choline-Cl medium containing 20 mM imidazole, pH
7.0, 4 nM [3H]ryanodine, 5 mM choline AMP, 5 mM choline
EGTA, 20 WM leupeptin, and 0.2 mM Pefabloc. Membranes were
incubated for 44 h at 12‡C. Data are expressed as % of maximum
activity in KCl medium and are the means þ S.E.M. of 3^5 experi-
ments.
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the recombinant RyR2 (Fig. 2). Membranes of cells trans-
fected with chimeras R4, R6 and R10 did not show speci¢c
high-a⁄nity [3H]ryanodine binding. Absence of [3H]ryanodine
binding was not due to lack of expression of the chimeras, as
immunoblots indicated similar expression levels for all six
chimeras (not shown).
Signi¢cant levels of [3H]ryanodine binding were observed in
choline-Cl media at low Ca2 concentrations for skeletal but
not cardiac muscle SR vesicles, which suggests that choline is
a weak Ca2 agonist of RyR1 but not RyR2 [13]. The inset of
Fig. 2 shows that membranes of cells expressing RyR1 bound
[3H]ryanodine in 0.5 M choline-Cl medium containing 6 1038
M free Ca2, whereas cells expressing RyR2 did not. Cells
transfected with R1 (Fig. 2, inset) and the other chimeras
(not shown) did not show speci¢c [3H]ryanodine binding in
choline media in the absence of Ca2. The results are in agree-
ment with previous mutagenesis studies that have localized the
Ca2 activation site(s) to the C-terminal one-fourth of RyRs
[14^16].
3.2. Single channel measurements
We also carried out single channel measurements because
these provide a more direct means of determining the activity
and Ca2 dependence of the chimeras. We determined the
single channel activities of two chimeras, R1 which showed
Ca2-dependent [3H]ryanodine binding and R4 which did not
show speci¢c [3H]ryanodine binding. R2 and R9 showed a
Ca2 dependence of [3H]ryanodine binding similar to R1
and were therefore not further studied. R6 and R10 were
not characterized because single channel conductances or ac-
tivities resembling those of native or recombinant RyRs were
not observed.
Channel activity of puri¢ed R1 and R4 chimeras was re-
corded in KCl media with di¡erent additions in the cis (SR
cytosolic) bilayer chamber. In 250 mM symmetrical KCl so-
lution, R1 and R4 had a mean conductance of 800 þ 8 pS
( þ S.E.M., n = 8) and 769 pS (n = 2), respectively, which was
essentially identical to that of native RyRs (not shown). In
Fig. 3A, a single R1 channel was recorded in the presence of
¢ve di¡erent cis (SR cytosolic) Ca2 concentrations. Infre-
quent, brief and sometimes not fully resolved channel open-
ings were recorded at 1.1 WM free Ca2. Elevation of cytosolic
Ca2 to 11 WM greatly increased channel open probability
(Po). The channel was nearly fully activated at 100 WM
Ca2 and retained a high level of activity at 1 mM Ca2. A
further increase to 10 mM Ca2 reduced Po to a low level,
similar to that seen at 1.1 WM Ca2. Fig. 3B compares the
Ca2 dependence of R1 with native skeletal and cardiac
muscle RyRs. The extent of activation by Ca2 as well as
the Ca2 activation/inactivation pro¢le of R1 were similar
to RyR2. The results indicate that the C-terminus has a role
in Ca2 inactivation of RyR1. Furthermore, the data of Fig. 3
suggest that a reduction in the a⁄nity of the inactivation sites
for Ca2 results in the formation of a RyR1/RyR2 chimera
that can be nearly fully activated by Ca2.
Fig. 4 (upper trace) shows a single Ca2-activated R4 chan-
nel recorded in an asymmetric KCl solution. The lower trace
of Fig. 4 shows that the R4 channel is sensitive to ryanodine.
As observed for native cardiac ryanodine receptors [4,5], the
addition of 10 WM cis ryanodine locked the R4 chimera in a
sub-conductance state with occasional closings. R4 was modi-
¢ed by 10 WM ryanodine in two of two recordings. R4 showed
Fig. 3. Ca2 dependence of single channel activities of R1 chimera.
A: Proteoliposomes containing puri¢ed R1 were fused with a planar
lipid bilayer. Currents of a single puri¢ed R1 channel, shown as
downward de£ections from closed level (c), were recorded at a hold-
ing potential of 335 mV in symmetrical 0.25 M KCl solution con-
taining the indicated free cytosolic Ca2 concentrations. The de-
crease in conductance at 10 mM Ca2 was due to the blocking
action of Ca2. B: Comparison of Ca2 activation/inactivation pro-
¢les of R1 (b) with native RyR1 (a) and RyR2 (P). Values for R1
are the mean þ S.E.M. of 4^7 experiments. Data for RyR1 and
RyR2 are the averages of two experiments each. Solid lines were
obtained by ¢tting data to a two-site (one activation, one inactiva-
tion) logistic function [13]. Derived Hill constants and coe⁄cients
for R1 are Ka = 5.1 WM Ca2, na = 1.4, Ki = 2860 WM Ca2, and
ni = 2.1.
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cardiac-type activity being maximally activated at 1 mM Ca2
in 250 mM KCl solution.
4. Discussion
Nakai et al. [8] expressed the six RyR1/RyR2 chimeras used
in the present study in dyspedic myotubes that lack an endog-
enous RyR1. The results indicated that two regions of RyR1
are important for the reciprocal interaction with skeletal
muscle surface membrane DHPR. Chimeras R1, R4, R6
and R10 all restored skeletal muscle excitation-contraction
(E-C) coupling and enhanced surface membrane DHPR
Ca2 channel function. Chimera R9 enhanced surface mem-
brane Ca2 channel function without restoring skeletal-type
E-C coupling. Chimera R2 neither restored skeletal muscle E-
C coupling nor enhanced surface membrane Ca2 channel
function but it encoded a functional protein because it re-
leased Ca2 in response to application of 0.1 mM ca¡eine
to the myotubes.
In the present study, a heterologous expression system was
used to identify protein regions that are important for the
regulation of the RyR1/RyR2 chimeras by Ca2. Mutagenesis
has been previously used to identify Ca2 regulatory sites in
RyRs. Three lines of evidence suggest that the C-terminal one-
fourth of RyRs has a critical role in Ca2 activation. First,
antibodies raised against a negatively charged sequence (aa
4489^4499, PEPEPEPEPEPE) blocked Ca2-dependent acti-
vation of the channel [14]. Second, the mutation E3885A in
RyR3 (equivalent to E4032A in RyR1) formed a functional
channel with normal conductance but with greatly decreased
Ca2 sensitivity [15]. Third, a deletion mutant encoding the
carboxy-terminal 1377 amino acids of RyR1 could be acti-
vated by WM Ca2 [16]. In the present study, we used the
weak RyR1 Ca2 agonist choline [13] to localize the Ca2
activation region of RyR1. In agreement with the previous
studies reporting a C-terminal localization of Ca2 activation
sites, we found that the weak RyR1 Ca2 agonist choline did
not activate R1, R2 and R9 chimeras.
Less is known about the location of Ca2 inactivation
site(s). Unlike the full-length RyR1, truncated RyR1 (v1^
3660) failed to close at high [Ca2], suggesting that the N-
terminal foot structure has a role in Ca2 inactivation [16].
At variance with this result is our ¢nding that the chimeric
construct R1 (RyR1(1^3720)/RyR2(3687^4968)) showed a re-
duced channel inactivation at elevated Ca2 concentrations,
similar to RyR2. A reduced channel inactivation at mM Ca2
concentrations was also observed for R2 and R9. Common to
these two chimeras and R1 is that the 3721^5037 amino acid
C-terminal region in RyR1 is replaced by the corresponding
region of RyR2. Our results therefore suggest that the C-ter-
minus of RyR1 has a major role in Ca2 inactivation. The
reasons for the di¡erences in the results of Bhat et al. [16] and
those of the present study are not known but they may be due
to restrictions inherent in using deletion mutants and chimeric
constructs. A limitation of the present study is that the Ca2
dependence of the reversed R1 chimera (RyR2(1^3686)/
RyR1(3721^5037)) was not determined. We constructed a
full-length reverse R1 cDNA, however, the expression levels
were very low. Furthermore, immunoblotting with isoform-
speci¢c antibodies indicated the absence of a 560 kDa RyR
band. Instead two proteolytic fragments were detected corre-
sponding in size to the RyR2 N-terminal and RyR1 C-termi-
nal regions (unpublished studies).
The biphasic Ca2 dependence of RyR1 indicates the pres-
ence of two classes of Ca2 binding sites, a high-a⁄nity acti-
vation site and a low-a⁄nity inactivation site. According to
this model, removal of the Ca2 inactivation site should result
in an increased activation by Ca2. In support of this sugges-
tion, we found that in single channel measurements R1, like
RyR2, was nearly fully activated by Ca2 alone.
An intriguing result was that replacement of RyR1 regions
with corresponding RyR2 regions resulted in a loss of high-
a⁄nity [3H]ryanodine binding in three of the six chimeras.
The high-a⁄nity [3H]ryanodine binding site in RyR1 has
been localized to a region [17,18] corresponding to the
3687^4968 amino acid C-terminal region of RyR2 that is
common to the six chimeras. However, protein conformation-
al changes mediated by the N-terminal portion have been
shown to be important for ryanodine binding. In support of
a long-range control are trypsin digestion studies in which the
intact 30S RyR1 protein complex was degraded to a 15S
complex. When the intact RyR1 complex bound
[3H]ryanodine before trypsin treatment, a 15S complex con-
taining the C-terminus [17] retained [3H]ryanodine binding,
whereas the 15S complex by itself was incapable of binding
[3H]ryanodine [19]. The present study also indicates that pro-
tein conformational changes mediated by the N-terminal por-
tion are important for ryanodine binding, as high-a⁄nity
[3H]ryanodine binding was lost in R4, R6 and R10. However,
it should also be noted that high-a⁄nity [3H]ryanodine bind-
ing and characteristic K conductance were observed for R1,
which suggests a normally functioning channel with the ex-
ception of an altered Ca2 dependence. A reduction of a⁄nity
rather than complete loss of speci¢c [3H]ryanodine binding
was observed for R4 which was locked by 10 WM ryanodine
in a sub-conductance state typical for RyRs. An important
feature of the single channel method is that it can test ryano-
dine binding at micromolar to millimolar concentrations,
whereas [3H]ryanodine binding measurements with the re-
combinant RyRs were limited to nanomolar concentrations.
In conclusion, six RyR1/RyR2 chimeras were used to show
that the C-terminal fourth plays an important role both in the
Fig. 4. Ryanodine modi¢cation of R4 chimera. Currents of a single
puri¢ed R4 channel, shown as upward de£ections from closed level
(c), were recorded at a holding potential of 330 mV in an asym-
metric 400 mM cis KCl/20 mM trans KCl solution with 100 WM
free Ca2 in the cis chamber before (upper trace) and 10 min after
(lower trace) the addition of 10 WM ryanodine to the cis chamber.
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activation and inactivation of the RyR1 by Ca2. The results
further suggest that replacement of RyR1 with RyR2 regions
may result in long-range protein conformational changes. Our
data point to one of these changes by showing a reduction in
[3H]ryanodine binding a⁄nity for one chimera that main-
tained channel activity.
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